FR252921, a novel immunosuppressive agent isolated from Pseudomonas fluorescens no. 408813 III. In vivo activities

J Antibiot (Tokyo). 2003 Feb;56(2):68-71.

Abstract

A novel immunosuppressive agent, FR252921 was isolated from the cultured broth of a species of Pseudomonas fluorescens. We have shown that FR252921 inhibit activating protein-1 (AP-1) transcription activity and act dominantly against antigen presenting cells comparing to T cell. Possibility of FR252921 as concomitant drug of FK506, T-cell specific inhibitor was evaluated. FR252921 showed synergy with FK506 in immunosuppressive activity both in splenic proliferation and in murine skin transplantation.

MeSH terms

  • Animals
  • Cell Division / drug effects
  • Cell Division / immunology
  • Drug Synergism
  • Female
  • Graft Survival / drug effects
  • Graft Survival / immunology
  • Immunosuppressive Agents / isolation & purification
  • Immunosuppressive Agents / pharmacology*
  • Lactams / isolation & purification
  • Lactams / pharmacology*
  • Lactones / isolation & purification
  • Lactones / pharmacology*
  • Lymphocyte Activation / drug effects
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mycophenolic Acid / analogs & derivatives
  • Mycophenolic Acid / pharmacology
  • Pseudomonas fluorescens / chemistry*
  • Pseudomonas fluorescens / metabolism
  • Skin Transplantation / immunology
  • T-Lymphocytes / cytology
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology
  • Tacrolimus / pharmacology

Substances

  • FR 252921
  • Immunosuppressive Agents
  • Lactams
  • Lactones
  • Mycophenolic Acid
  • Tacrolimus